Renuva® & alloClae™ — Volume Your
Body Grows Itself

Both are allograft adipose matrices — donated, purified human fat — but from different manufacturers and formulated for different zones. Renuva® (MTF Biologics) comes in 3 mL syringes and is used for the face: temples, tear troughs, cheeks, prejowl, hands, and décolleté. alloClae™ (Tiger Aesthetics) comes in 12.5 mL and 25 mL syringes and is used for the body: hip dips, upper buttock, breast contour, cleavage, and liposuction divots. alloClae is not used on the face.

Yes — and the honest answer matters. Both products use adipose tissue donated under the Uniform Anatomical Gift Act, the same framework that governs skin grafts, corneal transplants, and the orthopedic allografts used in ACL reconstruction. Donors consent to cosmetic use. Tissue is FDA-regulated, screened for communicable disease, and aseptically processed — no harsh chemicals, no terminal irradiation. What’s placed is an acellular scaffold your body replaces with its own tissue.

Because the matrix is replaced by your own adipose tissue over 3–6 months, what remains is native fat. It is subject to the same long-term behavior as any of your natural fat — stable in weight-stable patients, diminished with significant weight loss. There is no “wear-off” date the way there is with hyaluronic filler.

The matrix is processed to remove the cellular components that trigger rejection. What remains is an acellular scaffold. Peer-reviewed studies have not demonstrated rejection response in standard use. Every patient is screened for contraindications at consultation with Dr. Sandhu.

alloClae™ achieves subtle-to-moderate gluteal volume enhancement in-office, without general anesthesia and without the fat embolism risk associated with Brazilian Butt Lift surgery. It is not a volumetric substitute for a full BBL result — but for patients who want contour refinement, don’t qualify for surgery, or want the aesthetic without the operating room, it is a compelling alternative.

Face protocols with Renuva® typically use 1–3 mL per zone. Body protocols with alloClae™ range from 25 mL to several hundred mL depending on zone and outcome goal. Dr. Sandhu determines appropriate volume at consultation based on your anatomy and the result you’re seeking.

Face protocols: mild swelling and tenderness for 2–5 days; most patients return to work the next day. Body protocols: tenderness and potential bruising for 5–7 days, with return to full exercise around 2 weeks. No compression garment, no operating room recovery, no time off for anesthesia.